Skip to content
November 22, 2026
  • Home
  • National News
    • Metro News
      • metro
    • Society
    • Politics
    • Crime and Justice
  • Special Reports
    • Investigation
    • Features
    • Interviews
  • Opinion
    • Business & Economy
    • Commentaries
    • Perspectives
  • Press Releases
  • International News
Political Economist

Political Economist

A liberal News reporting Politics, Sports, Business, Commentaries

  • Home
  • National News
    • Metro News
      • metro
    • Society
    • Politics
    • Crime and Justice
  • Special Reports
    • Investigation
    • Features
    • Interviews
  • Opinion
    • Business & Economy
    • Commentaries
    • Perspectives
  • Press Releases
  • International News
Watch Online
  • Home
  • National News
  • AstraZeneca’s Tagrisso, chemo combination shows promise in lung cancer trial
  • National News

AstraZeneca’s Tagrisso, chemo combination shows promise in lung cancer trial

Admin May 17, 2023

May 17, 2023

The combination of AstraZeneca’s cancer drug, Tagrisso, with chemotherapy to treat patients with a type of lung cancer showed positive results in a late-stage trial, the company said on Wednesday.

The drug maker said patients on the combined treatment showed a meaningful improvement in progression-free survival, or how long a patient lives without the disease getting worse after treatment, than patients given only Tagrisso.

The trial was on patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer.

“Tagrisso has the potential to offer patients in the first-line setting a new treatment option that can extend the time they live without their disease progressing,” Susan Galbraith, executive vice president of AstraZeneca’s oncology R&D division said in a statement.

Analysts at Barclays have already flagged the threat of potential competition, especially with Johnson & Johnson  running a head-to-head trial with its own drug, Rybrevant.

REUTERS

  • Facebook
  • Share on X
  • LinkedIn
  • WhatsApp
  • Email
  • Copy Link
Tags: AstraZeneca Johnson&Johnson Susan Galbraith

Post navigation

Previous Plateau attack: Police arrest 5 suspects, recover AK47 rifle, revolver
Next Senate urges CBN to release $717.4m trapped airlines fund

Related Stories

Kenya’s Cabinet Secretary Honoured With Global Alliance-APRA’s Global Icon Award
  • National News

Kenya’s Cabinet Secretary Honoured With Global Alliance-APRA’s Global Icon Award

November 20, 2026
President confers National Honour, GCON, on Wole Olanipekun at his book presentation
  • National News

President confers National Honour, GCON, on Wole Olanipekun at his book presentation

November 20, 2026
Schools must certify 75% of teachers to register WAEC, NECO candidates – TRCN TRCN
  • National News

Schools must certify 75% of teachers to register WAEC, NECO candidates – TRCN

November 18, 2026
logo

Political Economist is a liberal news magazine with global affiliations.

At Political Economist, we promote free enterprise and act as a catalyst for the growth of knowledge economy. We are proudly pan-Nigeria yet richly spiced with African and global news. We offer a fair and balanced news reportage presented by our team of well-heeled professional journalists. <

About us

  • 5 Olutosin Ajayi Street, By CPM Church, Ajao Estate, Lagos State, Nigeria
  • +234 805 680 1124
  • info@politicaleconomistng.com

You may have missed

Court remands 11 Malians in Suleja Correctional Centre over alleged kidnapping FG vs ASUU
  • Crime and Justice

Court remands 11 Malians in Suleja Correctional Centre over alleged kidnapping

November 20, 2026
How I escaped assassination, Segun Odegbami narrates ordeal
  • Sports

How I escaped assassination, Segun Odegbami narrates ordeal

November 20, 2026
FIFA President applauds Oborevwori’s investment in sports, hails Warri Stadium remodelling
  • Sports

FIFA President applauds Oborevwori’s investment in sports, hails Warri Stadium remodelling

November 20, 2026
Edo’s continued development depends on Tinubu’s second term– Okpebholo
  • Politics

Edo’s continued development depends on Tinubu’s second term– Okpebholo

November 20, 2026
  • Home
  • National News
    • Metro News
      • metro
    • Society
    • Politics
    • Crime and Justice
  • Special Reports
    • Investigation
    • Features
    • Interviews
  • Opinion
    • Business & Economy
    • Commentaries
    • Perspectives
  • Press Releases
  • International News
Copyright © All rights reserved. | DarkNews by AF themes.